Skip to main content
Ingredients/Fatty acid/Phosphatidylinositol 4,5-Diphosphate

Phosphatidylinositol 4,5-Diphosphate.

Read pending.Phosphatidylinositol 4,5-Diphosphate is in the library; the clinical read is in the queue.

Research-backed fatty acid with potential health benefits. Phospholipid that's a key signal molecule in cell membranes.

100 to 300mgDaily amount4,128Studies read

Reviewed March 2026

PDFatty acid
Phosphatidylinositol 4,5-DiphosphateIngredientMD
Category
Fatty acid

What Phosphatidylinositol 4,5-Diphosphate is, and what it does.

Does it work
Fascinating biology, but not a supplement target.
How much to take
Start with 100 to 300mg a day for daily maintenance. Nobody has measured what an oral amount of this lipid does in people, so that band is not anchored to a human outcome.
Time to feel it
There is no measured onset. Cells make and break this lipid down within seconds, and no human study has tracked an oral amount against a timeline.
The first dose
Day one passes without a sensation. Any swallowed phospholipid is cleaved and rebuilt in the gut wall, so the first day is biochemistry rather than an experience.
With regular use
Nobody has run a long-term human study on it. What is established is the biochemistry: cells rebuild this lipid continuously from their own phosphatidylinositol pool.
How well tolerated
Oral dosing has not been studied in people, so tolerance is not documented either way. Phospholipids from food are well tolerated. Check with your doctor first.
How it feels
No subjective experience has been described for it. This is a signalling lipid working at the inner face of a membrane, and its effects are measured in cells.
The overlooked benefit
Position is everything. The same lipid with its phosphates on different spots of the inositol ring does completely different jobs, which is why batch checks matter here.

100 to 300mg a day is where Phosphatidylinositol 4,5-Diphosphate works.

How much to take a dayLimited data
100 to 300mg
Daily maintenanceThe everyday amount, and where most daily supplements sit. This is the one you take month after month.
600mgClinical territory. Trials run high on purpose, for a set number of weeks, against one measured outcome. Impressive to hit, and not what a daily product is for.
Above 1,000mgPast what the research covers. More capsules rather than more effect.
MORE EFFECT ↑0300mg600mg plateauDAILY DOSE →
The shaded band is where the dosing trials landed.

Source: Cell signaling literature; no established supplement dosing

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

Read pending.

Phosphatidylinositol 4,5-Diphosphate is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.

  • Second messenger release through phospholipase CIn vitro study
  • Calcium release from internal storesIn vitro study
  • Gating of inwardly rectifying potassium channelsIn vitro study
  • Recruitment of signalling proteins to the inner membraneIn vitro study
  • Cytoskeleton attachment at the membrane surfaceIn vitro study
  • Outcomes from oral supplementation in peopleNarrative review
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI4,128 studies readLabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI4,128 studies readLabs test. IngredientMD verifies.

Questions people ask about Phosphatidylinositol 4,5-Diphosphate.

When should I take it?
Timing matters less than consistency. Pick a time that works for you and take it daily.
Can I take it with other supplements?
Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
Any side effects to watch for?
Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Pairs well with15 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

Myo-inositol is the head group of every phosphoinositide, and phosphatidylinositol is assembled from CDP-diacylglycerol and free inositol before any phosphate is added to the ring. Dietary inositol and inositol made from glucose-6-phosphate both feed that pool. This is the direct precursor relationship for the molecule.

Phosphatidylinositol 4,5-Diphosphate + MagnesiumEstablished enzyme cofactor chemistry

The lipid kinases that add phosphate to positions 4 and 5 of the inositol ring use ATP as the phosphate donor, and ATP acts as a magnesium complex at every kinase active site. Magnesium is therefore a condition for making this lipid at all. The relationship is general to kinases and settled.

Each molecule carries a phosphodiester linking the glycerol backbone to inositol plus two further phosphate groups on the ring, so phosphate supply is structural rather than incidental. Dietary phosphorus feeds the cellular phosphate pool that ATP and the phospholipids draw on. This is compositional biochemistry.

Phosphatidylinositol 4,5-Diphosphate + CholineShared phospholipid synthesis machinery

Phosphatidylcholine and phosphatidylinositol are both built on a diacylglycerol backbone through CDP-linked intermediates, so they draw on the same lipid pool from different branches. Choline availability governs the phosphatidylcholine branch specifically. The branches share substrate rather than substituting for one another.

Phosphatidylcholine is the bulk structural phospholipid of cell membranes while phosphoinositides are minor components that act as signals within them. The signalling lipids sit inside a bilayer the bulk lipids form. Membrane composition is what makes the signalling geometry possible.

Phosphatidylinositol 4,5-Diphosphate + PhosphatidylserineShared membrane lipid pool and inner-leaflet charge

Phosphatidylserine and the phosphoinositides are the main negatively charged lipids of the inner leaflet of the plasma membrane, and together they create the electrostatic surface that recruits proteins to it. Neither can be replaced by the other in that role. The chemistry is described at the level of membrane surface charge.

Lecithin is a mixed phospholipid fraction that contains phosphatidylinositol alongside phosphatidylcholine and phosphatidylethanolamine, so it supplies the unphosphorylated parent lipid rather than the phosphorylated signalling form. Cells add the 4 and 5 phosphates themselves; that step is not supplied by any food. This distinction is the important one for anyone reading a supplement label.

Phosphatidylinositol 4,5-Diphosphate + CalciumEstablished downstream signalling chemistry

When phospholipase C cleaves this lipid it releases inositol 1,4,5-trisphosphate, which opens IP3 receptor channels on the endoplasmic reticulum and lets stored calcium into the cytosol. Calcium is the downstream messenger of the pathway rather than a co-supplement for it. The step is one of the most thoroughly described in cell signalling.

Phosphatidylinositol 4,5-Diphosphate + Omega-3 fish oil (EPA/DHA)Established membrane acyl composition chemistry

Phosphatidylinositol species carry a characteristic stearoyl and arachidonoyl acyl pair, and dietary long-chain fatty acid intake changes the acyl composition of membrane phospholipids over weeks. Altering that composition changes membrane fluidity and the substrate pool available to phospholipases. The compositional effect is established; what it means for any single signalling event is not.

Phosphatidylinositol 4,5-Diphosphate + Linoleic acidEstablished precursor chemistry for the acyl chain

Arachidonic acid, the fatty acid most enriched at the second position of phosphatidylinositol, is made from dietary linoleic acid through desaturation and elongation. That makes linoleic acid the upstream supply for the acyl side of the molecule rather than for its head group. The conversion pathway is settled and its efficiency varies between people.

Phosphatidylinositol 4,5-Diphosphate + L-SerineEstablished phospholipid head-group chemistry

Phosphatidylserine is made by base exchange in which serine replaces the head group of an existing phospholipid, drawing on the same backbone pool that phosphoinositides come from. Serine supply governs that branch. The two anionic inner-leaflet lipids share their origin.

Phosphatidylinositol 4,5-Diphosphate + Alpha-GPCRelated phospholipid metabolite chemistry

Alpha-glycerophosphocholine is a deacylated phospholipid metabolite that feeds both choline supply and the glycerophospholipid backbone pool. It enters the same lipid economy that phosphoinositide synthesis draws on, at a different point. Read the link as shared substrate rather than as a joint effect.

Phosphatidylinositol 4,5-Diphosphate + CDP-cholineEstablished phospholipid synthesis intermediate

CDP-choline is the activated intermediate of the Kennedy pathway that builds phosphatidylcholine onto a diacylglycerol backbone. Diacylglycerol is also the fragment released when phospholipase C cleaves this phosphoinositide, so the two pathways meet at that molecule. The connection is a shared intermediate, described in textbooks.

Phosphatidylinositol 4,5-Diphosphate + ZincEstablished enzyme structural chemistry

Protein kinase C, the enzyme activated by the diacylglycerol released from this lipid, carries zinc-binding structural domains in its regulatory region. Zinc there is structural rather than catalytic. It is a settled feature of the enzyme's architecture rather than a supplementation finding.

Phosphatidylinositol 4,5-Diphosphate + PotassiumEstablished ion channel regulation

Several inwardly rectifying potassium channels require this lipid bound at the membrane face to stay open, one of the clearest examples of a phosphoinositide acting directly on a channel rather than through a second messenger. Depleting the lipid closes those channels. The relationship is well characterised in electrophysiology.

Who should be cautious

Nothing specific on file for Phosphatidylinositol 4,5-Diphosphate. Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What Phosphatidylinositol 4,5-Diphosphate actually does.

Established

Phosphatidylinositol 4,5-bisphosphate is a phospholipid with a diacylglycerol backbone and a myo-inositol head group carrying phosphate groups at the 4 and 5 positions of the ring; it is a minor component of the inner leaflet of the plasma membrane rather than a bulk structural lipid.

Established

Phospholipase C cleaves it into two second messengers at once: inositol 1,4,5-trisphosphate, which is water soluble and diffuses to release calcium from the endoplasmic reticulum, and diacylglycerol, which stays in the membrane and activates protein kinase C.

Established

Phosphoinositide 3-kinase phosphorylates it at the 3 position to make phosphatidylinositol 3,4,5-trisphosphate, the membrane docking site that recruits pleckstrin homology domain proteins to the inner face of the membrane.

Established

It is built in sequence: phosphatidylinositol is phosphorylated at the 4 position by PI4 kinase, then at the 5 position by PIP5 kinase, with ATP as the phosphate donor at both steps.

More than one route, 6 steps on record

Where Phosphatidylinositol 4,5-Diphosphate comes from.

The starting material is either a phospholipid fraction pulled from soy or sunflower lecithin or a molecule built from scratch. Phosphate groups are then added at two exact spots on the inositol ring. Getting them on the right spots is the hard part, because near-identical versions with the phosphates elsewhere do completely different things in a cell, so the batch is separated and checked before it is dried and kept cold.

The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.

Starts as
Oilseed lecithin or synthetic inositol and fatty acids

Natural-chain material starts from soy or sunflower lecithin or from animal tissue; synthetic analogues start from protected myo-inositol and defined fatty acids.

Extracted by
Phospholipid fractionation

Lecithin is fractionated with solvents and chromatography to concentrate the acidic phospholipid fraction containing phosphatidylinositol.

Converted by
Phosphorylation

The 4 and 5 ring positions are phosphorylated either enzymatically with lipid kinases and ATP or by protected chemical synthesis, which is where the regiochemistry is decided.

Purified by
Ion-exchange and preparative chromatography

Positional isomers such as the 3,4- and 3,5-bisphosphates are separated, since they are chemically close and biologically different.

Standardised to
Identity and purity assay

Structure and isomer purity are confirmed by mass spectrometry and nuclear magnetic resonance, and the counter-ion is defined.

Ends up as
Lyophilised salt or lipid film

Dried under inert gas and stored cold, because the polyunsaturated acyl chains oxidise and the phosphate esters hydrolyse over time.

Getting Phosphatidylinositol 4,5-Diphosphate from food.

The whole-food sources on file. A supplement closes the gap, it does not replace dinner.

Egg yolkBeef liverSoybeans, the source of lecithin

A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.

The forms it comes in.

PIP2 ammonium saltThe natural-chain lipid isolated from tissue or produced enzymatically and supplied as an ammonium salt, the standard handling form for a highly charged lipid.Fits Laboratory work where the natural long acyl chains and the full charge are required.Trade-off It is poorly water dispersible, needs vesicle or micelle preparation to be usable, and is a research material rather than a dietary format.
Short-chain synthetic diC8 PIP2A synthetic analogue with two eight-carbon acyl chains, which makes the molecule water soluble instead of membrane bound.Fits Experiments that need the head group delivered in solution, such as channel and enzyme assays.Trade-off The short chains change how the molecule partitions into membranes, so it does not behave like the natural long-chain lipid.
What the strongest studies found

The essence, in one line each.

  1. The review describes phosphoinositides and inositol phosphates as membrane signalling lipids and their soluble products, with phosphatidylinositol 4,5-bisphosphate positioned as the substrate for phospholipase C and phosphoinositide 3-kinase.Narrative review. Cheng Z et al., 2025 (Clinical Science). PMID 41032702
  2. The authors report shifts in membrane lipid species, phosphoinositides among them, when donor rat livers were perfused under the conditions studied.Animal study. Minami Y et al., 2026 (Journal of Lipid Research). PMID 41999982
  3. Transcriptome profiling of serum-derived exosomes returned phosphoinositide signalling among the enriched pathway terms, which the authors present as an association within a profiling dataset.Case-control. Yang G et al., 2026 (Diagnostics). PMID 41594224

These are the studies our verdict leans on, chosen from the 3 we read for Phosphatidylinositol 4,5-Diphosphate. The full linked list is below.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.